Stem cell scarring aids recovery from spinal cord injury

In a new study, researchers at Karolinska Institutet in Sweden show that the scar tissue formed by stem cells after a spinal cord injury does not impair recovery; in fact, stem cell scarring confines the damage. The findings, which are published in the scientific journal Science, indicate that scar tissue prevents the lesion from expanding and helps injured nerve cells survive.

Spinal cord injuries sever nerve fibres that conduct signals between the brain and the rest of the body, causing various degrees of paralysis depending on the site and extent of the injury. Functional impairment is often permanent, since the cut nerve fibres do not grow back. The lack of regeneration has been attributed to a blockage from that forms at the lesion. It has therefore been suggested that the nerve fibres could regenerate and that recovery could improve if scar formation is inhibited, and many proposed therapeutic strategies have been designed around this concept.

In the present study, the researchers focused on spinal cord , which are one of the main sources of the scar tissue that is formed after spinal cord injury. They found that when blocking scar formation by preventing the stem cells from forming new cells after an injury, the injury gradually expanded, and more were severed. They also observed that more spinal cord died in these mice compared to mice with intact stem cell function, which were able to form normal scar tissue.

"It turned out that scarring from stem cells was necessary for stabilising the injury and preventing it from spreading," says principal investigator Professor Jonas Frisén at the Department of Cell and Molecular Biology. "Scar tissue also facilitated the survival of damaged nerve cells. Our results suggest that more rather than less stem cell scarring could limit the consequences of a spinal cord injury."

This video is not supported by your browser at this time.

According to earlier animal studies, recovery can be improved by transplanting stem cells to the injured spinal cord. The new findings suggest that stimulating the 's own stem cells could offer an alternative to cell transplantation.

More information: 'Resident Neural Stem Cells Restrict Tissue Damage and Neuronal Loss After Spinal Cord Injury in Mice', Hanna Sabelström, Moa Stenudd, Pedro Réu, David O. Dias, Marta Elfineh, Sofia Zdunek, Peter Damberg, Christian Göritz, Jonas Frisén, Science, online 1 November 2013.

Related Stories

Unexpected cell repairs injured spinal cord

Jul 07, 2011

Lesions to the brain or spinal cord rarely heal fully, which leads to permanent functional impairment. After injury to the central nervous system (CNS), neurons are lost and largely replaced by a scar often referred to as ...

Damaged spinal cord tissue repaired by stem cells

Oct 08, 2010

Researchers at Karolinska Institutet have shown how stem cells, together with other cells, repair damaged tissue in the mouse spinal cord. The results are of potential significance to the development of therapies for spinal ...

Stem cells used to reverse paralysis in animals

Jan 28, 2009

A new study has found that transplantation of stem cells from the lining of the spinal cord, called ependymal stem cells, reverses paralysis associated with spinal cord injuries in laboratory tests. The findings show that ...

Recommended for you

Leeches help save woman's ear after pit bull mauling

2 hours ago

(HealthDay)—A pit bull attack in July 2013 left a 19-year-old woman with her left ear ripped from her head, leaving an open wound. After preserving the ear, the surgical team started with a reconnection ...

New pain relief targets discovered

14 hours ago

Scientists have identified new pain relief targets that could be used to provide relief from chemotherapy-induced pain. BBSRC-funded researchers at King's College London made the discovery when researching ...

Building 'smart' cell-based therapies

15 hours ago

A Northwestern University synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other ...

User comments